Cargando…

2079. The Relation Between Panel Reactive Antibody Assay and Cytomegalovirus Reactivation in Seropositive Solid Organ Transplantation Recipients

BACKGROUND: Cytomegalovirus (CMV) can lead to severe morbidities and mortalities including pneumonia in particular as well as graft dysfunction through indirect immunomodulation in solid-organ transplantation recipients. High degree of HLA mismatch is a well-known risk factor of post-transplant (Tx)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Da Eun, Lee, Kyoung Hwa, La, Yeonju, Yoo, Seul Gi, Han, Sang Hoon, Song, Young Goo, Lee, Jae Geun, Huh, Ku Ha, Kim, Myoung Soo, Choi, Jin Sub, Kim, Soon Il, Kim, Yu Seun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254122/ http://dx.doi.org/10.1093/ofid/ofy210.1735

Ejemplares similares

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

2510. Epidemiological Change of Cytomegalovirus Diseases in the Developed Country With High Cytomegalovirus–Seropositive Rate: Nationwide, Whole Population-Based Study
por: Yoo, Seul Gi, et al.
Publicado: (2018)

Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea
por: La, Yeonju, et al.
Publicado: (2019)

Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients
por: Lee, Kyoung Hwa, et al.
Publicado: (2019)

2079: Updates to the documentation system for R
por: Middleton Redd, Andrew
Publicado: (2018)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2018)

Immunotherapy -2079. Comparison of house dust mite specific IgE and IgG4 between patients receiving rush immunotheraopy and conventional immunotherapy
por: Lee, Ji-Ho, et al.
Publicado: (2013)

The Incidence and Effect of Cytomegalovirus Disease on Mortality in Transplant Recipients and General Population: Real-world Nationwide Cohort Data
por: Han, Sang Hoon, et al.
Publicado: (2021)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Synthesis, Interfaces, and Nanostructures: A Section of Nanomaterials (ISSN 2079-4991)
por: Scrimin, Paolo
Publicado: (2021)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Stern, Lauren, et al.
Publicado: (2019)

Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group
por: Song, Young Hae, et al.
Publicado: (2012)

Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
por: Limaye, Ajit P., et al.
Publicado: (2020)

Cytomegalovirus reactivation in ICU patients
por: Papazian, Laurent, et al.
Publicado: (2015)

Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantation
por: Lee, Byung-Hyun, et al.
Publicado: (2023)

Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation
por: Emery, Vincent C., et al.
Publicado: (2012)

Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Lee, Su Hwan, et al.
Publicado: (2017)

Cytomegalovirus Reactivation in Adult Recipients of Autologous Stem Cell Transplantation: a Single Center Experience
por: Al-Rawi, Omar, et al.
Publicado: (2015)

Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients
por: Maggi, Fabrizio, et al.
Publicado: (2018)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Cecal Bascule as a Rare Presentation of Cytomegalovirus Colitis in a Kidney Transplant Recipient
por: Shim, Hong Gi, et al.
Publicado: (2019)

Invasive fungal infection in liver transplant recipients in a prophylactic era: A multicenter retrospective cohort study in Korea
por: Kim, Youn Jeong, et al.
Publicado: (2019)

Epigenetic Control of Cytomegalovirus Latency and Reactivation
por: Liu, Xue-feng, et al.
Publicado: (2013)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
por: Kim, You Sun, et al.
Publicado: (2015)

PB2079: LACTATE DECREASES BORTEZOMIB SENSITIVITY AND PREDICTS POOR CLINICAL OUTCOMES OF MULTIPLE MYELOMA
por: MA, Naya, et al.
Publicado: (2023)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection
por: Nakamura, Mônica Rika, et al.
Publicado: (2022)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss
por: Sherkat, Roya, et al.
Publicado: (2014)

Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study
por: Navarro-Rodríguez, Viviana, et al.
Publicado: (2017)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Dexamethasone: Cytomegalovirus proctitis following reactivation of cytomegalovirus infection: case report
Publicado: (2021)

Reactive oxygen species‐induced parthanatos of immunocytes by human cytomegalovirus‐associated substance
por: Kim, Jung Heon, et al.
Publicado: (2018)

Clinical Characteristics and Treatment Outcomes of Colorectal Cancer in Renal Transplant Recipients in Korea
por: Kim, Jeong Yeon, et al.
Publicado: (2011)

Consequences of cytomegalovirus reactivation in patients with severe sepsis
por: Heininger, A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_id7j1bbsvhi4llrcgqcgm7tpj9